CD8A and cancer: These results suggest that the gut microbiota plays an important role in the differentiation of donor precursor cells into immunogenic DCs suitable for cancer therapy and may enhance antitumor therapy by modulating gut microbes to optimize DC vaccines for enhanced dendritic cell function and activation of cytotoxic CD8+ T cells (20, 92).